Amnis and Tripos and NovaScreen | GenomeWeb

Amnis and Tripos and NovaScreen


Amnis Installs Cell Analysis Systems at Company, Academic, and Government Labs

Seattle-based Amnis said last week that it had recently installed its flagship technology, the ImageStream 100 Cell Analysis system, at three institutions as it prepares for a full commercial launch of the product next month.

The new ImageStream customers are Cell Therapeutics, the Fred Hutchinson Cancer Research Center, and the National Institute of Allergy and Infectious Disease. It had previously announced an installation at the Coriell Institute for Medical Research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.